ArticleScientific reports2026
Evaluating Punica granatum mediated AgNPs acaricidal activity against Rhipicephalus microplus and Sarcoptes scabiei using in vitro and in silico analyses.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Sarcoptic mange and tick infestations caused by Sarcoptes scabiei and Rhipicephalus microplus are growing veterinary and economic concerns globally. Resistance against traditional acaricides, coupled with growing concern for the environment, calls for the development of alternative control strategies. The current study aimed to develop and evaluate the acaricidal activity of silver nanoparticles (AgNPs) synthesized using a green methodology that involved the leaf extracts of Punica granatum. The AgNPs were characterized using UV-Visible spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy-dispersive X-ray (EDX) analysis. The synthesized AgNPs were also tested for their acaricidal activities using Adult Immersion Test (AIT), Larval Packet Test (LPT), contact bioassays, and molecular docking to determine the possible binding interactions of the bioactive metabolites with the respective target proteins. The results revealed the successful synthesis of crystalline AgNPs with a diameter of 25 to 80 nm, coupled with a strong signal for silver in the EDX analysis. The AgNPs also showed a promising bio efficacy and acaricidal activity against R. microplus and S. scabiei. In the contact bioassays, the acaricidal activity of the AgNPs extract was concentration dependent, with significant 100% mortality even at 2 mg/mL. The extract was even more active than the positive control, permethrin. In contact bioassays, prolonged exposure demonstrated an improvement in the LC₅₀ and LC₉₀ values, while the Adult Immersion Test showed a remarkable inhibition of oviposition. At a concentration of 40 mg/mL, 100% mortality rate, and 71.93% inhibition of egg-laying were observed with the AgNPs extract. This demonstrates significant suppression of tick reproduction. Computational analyses supported these findings. Structural homology of target proteins was validated using Ramachandran plots, ERRAT, and CASTp, while molecular docking showed that the most active compounds, benzene dicarboxylic acid and 3-amino-N-(pyridin-4-yl) propanamide had the highest binding affinities to the aspartic proteases of S. scabiei and R. microplus, thus aligning with the observed bioactivity. In silico studies underscored novel phytocompounds with strong inhibitory potential as the extract and the as-synthesized AgNPs exhibited potent acaricidal activity, underscoring them as promising candidates to replace synthetic acaricides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.